Markets
TMO

Thermo Fisher (TMO) Beats on Q3 Earnings & Sales Estimates

Involved in Scientific Research? Then you must have heard about MA-based Thermo Fisher Scientific Inc.TMO one of the leading scientific instrument manufacturers across the world. Interestingly for this acquisition-friendly company, the latest buy out of Life Technologies is expected to give birth to an unrivaled market leader serving research, Specialty Diagnostics and applied markets.

Currently, Thermo Fisher has a Zacks Rank #2 (Buy) but that could change following its promising third-quarter 2017 earnings report which has just released. (You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here ). We have highlighted some of the key details from the just-released announcement below:

Earnings: The current Zacks Consensus Estimate is pegged at $2.24 per share. Thermo Fisher's adjusted earnings per share of $2.31 is up 13.8% year-over-year in the reported quarter.

Revenues: Thermo Fisher posted third quarter revenues of $5.11 billion, which has also surpassed the Zacks Consensus Estimate for revenues of $5.03 billion.

Thermo Fisher Scientific Inc Price and EPS Surprise

Thermo Fisher Scientific Inc Price and EPS Surprise | Thermo Fisher Scientific Inc Quote

Key Stats : Among its four business segments in the reported quarter, Thermo Fisher delivered revenues of $1.38 billion (up 5%) in Life Sciences Solutions, $1.19 billion (up 32%) in Analytical Instruments, $844 million (up 6%) in Specialty Diagnostics and $1.93 billion (up 15%) in Laboratory Products and Services respectively.

Major Factors : Management seemed upbeat about its impressive third quarter results. Expansion in analytical instrument platforms for both life sciences and applied markets and contribution in gene therapy are key highlights of the quarter. The company has also raised its 2017 revenue and earnings guidance on the back of the acquisition of Patheon, strong operational performance and a more favorable foreign exchange environment.

Check back later for our full write up on this Thermo Fisher earnings report later!

Zacks' Hidden Trades

While we share many recommendations and ideas with the public, certain moves are hidden from everyone but selected members of our portfolio services. Would you like to peek behind the curtain today and view them?

Starting now, for the next month, I invite you to follow all Zacks' private buys and sells in real time from value to momentum...from stocks under $10 to ETF to option movers...from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors.

Click here for Zacks' secret trade>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Thermo Fisher Scientific Inc (TMO): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

TMO

Other Topics

Earnings Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More